Trial Profile
GLP-1 for bridging of hyperglycaemia during cardiac surgery: a randomized controlled trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jul 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Hyperglycaemia
- Focus Therapeutic Use
- Acronyms The GLOBE trial
- 11 Jun 2019 Primary endpoint (The proportion of patients needing insulin therapy in the perioperative period (morning of surgery until transfer to the Intensive Care Unit)) has been met, according to data presented at the 79th Annual Scientific Sessions of the American Diabetes Association.
- 11 Jun 2019 Results (n=278) were presented at the 79th Annual Scientific Sessions of the American Diabetes Association.
- 12 May 2019 This trial has been completed in Netherlands.